Skip to main content
. 2009 Nov 2;27(34):5700–5706. doi: 10.1200/JCO.2009.23.2025

Table 3.

MDACC Multivariable Models

Comparative Variable Multivariable Analyses by Survival Status
Recurrence Free
Distant Recurrence–Free
Hazard Ratio 95% CI P Hazard Ratio 95% CI P
HER2 status
    Positive v negative 2.68 1.44 to 5 .002 5.30 2.23 to 12.62 .0002
Hormone receptor status
    Positive v negative 0.41 0.23 to 0.72 .002 0.59 0.25 to 1.37 .219
Age at diagnosis, years* 0.96 0.94 to 0.98 .001 0.73 0.32 to 1.7 .467
Tumor grade
    3 v 1-2 1.34 0.75 to 2.41 .320 0.97 0.94 to 1 .080
Stage
    Ib v Ia 1.59 0.91 to 2.78 .103 1.47 0.68 to 3.18 .329

Abbreviations: MDACC, M. D. Anderson Cancer Center; HER2, human epidermal growth factor receptor 2.

*

Continuous variable.

HHS Vulnerability Disclosure